Function of JunB in Transient Amplifying Cell Senescence and Progression of Human Prostate Cancer
- 15 July 2008
- journal article
- Published by American Association for Cancer Research (AACR) in Clinical Cancer Research
- Vol. 14 (14), 4408-4416
- https://doi.org/10.1158/1078-0432.ccr-07-4120
Abstract
Purpose: Replicative senescence in cells acts as a barrier against excessive proliferation and carcinogenesis. Transient amplifying cells (TAC) are a subset of basal cell populations within the prostate from which cancers are thought to originate; therefore, we focused on prostate TAC to investigate the molecular mechanisms by which the TAC may be able to evade senescence. Experimental Design: TAC clones were isolated from each zone within the whole prostate and analyzed in flow cytometry. Prostate cancer cells were transfected with junB small interfering RNA (siRNA) and examined by chorioallantoic membrane assay for cancer invasion. Immunohistochemical analysis was done in primary and metastatic prostate cancer specimens. Results: TAC populations showed increased expression of p53, p21, p16, and pRb, resulting in senescence. TAC clones with reduced p16 expression successfully bypassed this phase. We further found close correlation between the levels of junB and p16 expression. Repeated transfection of junB siRNA in prostatic TAC allowed the cells to escape senescence presumably through inactivation of p16/pRb. The chorioallantoic membrane invasion assay showed much lower in invasive cancer cells with high expression of junB; conversely, silencing of junB by transfection with junB siRNA promoted invasion. We also found that metastatic prostate cancers, as well as cancers with high Gleason scores, showed significantly low junB immunopositivity. Conclusions: JunB is an essential upstream regulator of p16 and contributes to maintain cell senescence that blocks malignant transformation of TAC. JunB thus apparently plays an important role in controlling prostate carcinogenesis and may be a new target for cancer prevention and therapy.Keywords
This publication has 47 references indexed in Scilit:
- Low-Calcium Serum-Free Defined Medium Selects for Growth of Normal Prostatic Epithelial Stem CellsCancer Research, 2006
- JUN siRNA regulates matrix metalloproteinase-2 expression, microvascular endothelial growth and retinal neovascularisationJournal of Cell Science, 2006
- Sex steroids have differential effects on growth and gene expression in primary human prostatic epithelial cell cultures derived from the peripheral versus transition zonesCarcinogenesis: Integrative Cancer Research, 2005
- Phosphorylation status of Fas-associated death domain-containing protein (FADD) is associated with prostate cancer progressionThe Journal of Pathology, 2005
- A DNA damage checkpoint response in telomere-initiated senescenceNature, 2003
- DNA Damage Foci at Dysfunctional TelomeresCurrent Biology, 2003
- Promoter Specificity and Biological Activity of Tethered AP-1 DimersMolecular and Cellular Biology, 2002
- Sequential extension of proliferative lifespan in human fibroblasts induced by over-expression of CDK4 or 6 and loss of p53 functionOncogene, 2002
- Molecular disorders in transitionalvs. peripheral zone prostate adenocarcinomaInternational Journal of Cancer, 2001
- AP-1 in cell proliferation and survivalOncogene, 2001